Fidelity Advisor Biotechnology Fund (FBTIX) is an MF managed by Fidelity. Its largest position is AbbVie Inc. (ABBV), representing 14.83% of fund assets.
Fidelity Advisor Biotechnology Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FBTIX
- Type:
- MF
- Manager:
- Fidelity
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 26, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
AbbVie Inc.
|
14.83% | $282,213,633.60 | 1,335,480 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
5.52% | $105,067,522.14 | 339,486 |
|
-
GILEAD SCIENCES, INC.
|
5.42% | $103,219,676.00 | 788,900 |
|
-
INSMED Inc
|
3.51% | $66,747,168.00 | 489,600 |
|
-
Cogent Biosciences, Inc.
|
3.45% | $65,668,136.22 | 1,834,818 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
3.37% | $64,099,443.60 | 730,062 |
|
-
Spyre Therapeutics, Inc.
|
3.33% | $63,414,425.40 | 851,772 |
|
-
Ascendis Pharma A/S
|
3.24% | $61,754,830.50 | 269,225 |
|
-
ARGENX SE
|
3.17% | $60,348,784.00 | 77,200 |
|
-
BIOGEN INC.
|
2.92% | $55,667,248.00 | 294,100 |
|
-
Oruka Therapeutics, Inc.
|
2.65% | $50,444,576.26 | 737,386 |
|
-
FIDELITY REVERE STREET TRUST
|
2.51% | $47,778,747.22 | 47,773,970 |
|
-
AMGEN INC
|
2.46% | $46,779,413.75 | 135,103 |
|
-
Vaxcyte, Inc.
|
2.30% | $43,710,123.96 | 763,629 |
|
-
Revolution Medicines, Inc.
|
2.27% | $43,163,940.00 | 299,500 |
|
-
NUVALENT INC-A
|
2.17% | $41,341,833.92 | 412,264 |
|
-
Amylyx Pharmaceuticals, Inc.
|
2.05% | $38,931,200.00 | 2,433,200 |
|
-
APOGEE THERAPEUTICS INC
|
1.97% | $37,519,246.71 | 452,639 |
|
-
Moderna, Inc.
|
1.55% | $29,438,352.00 | 640,800 |
|
-
Xenon Pharmaceuticals Inc.
|
1.34% | $25,579,906.32 | 456,458 |
|
-
Viridian Therapeutics, Inc.\DE
|
1.26% | $24,027,614.72 | 1,782,464 |
|
-
Kiniksa Pharmaceuticals International, plc
|
1.18% | $22,458,528.00 | 417,600 |
|
-
Roivant Sciences Ltd.
|
1.16% | $22,159,251.00 | 776,700 |
|
-
Jade Biosciences, Inc.
|
1.15% | $21,821,969.20 | 894,343 |
|
-
Praxis Precision Medicines, Inc.
|
1.14% | $21,648,557.00 | 67,900 |
|
-
CRINETICS PHARMACEUTICALS INC
|
1.11% | $21,114,546.60 | 544,470 |
|
-
CYTOKINETICS INC
|
1.05% | $20,014,357.87 | 312,871 |
|
-
Structure Therapeutics Inc.
|
1.05% | $19,945,740.00 | 481,200 |
|
-
Kymera Therapeutics, Inc.
|
0.99% | $18,783,919.00 | 231,700 |
|
-
Natera, Inc.
|
0.97% | $18,430,704.00 | 89,400 |
|
-
APPLIED MATERIALS INC /DE
|
0.93% | $17,691,881.83 | 65,200 |
|
-
APPLIED MATERIALS INC /DE
|
0.88% | $16,747,584.00 | 586,400 |
|
-
FIDELITY REVERE STREET TRUST
|
0.77% | $14,684,985.85 | 14,682,049 |
|
-
Viking Therapeutics, Inc.
|
0.74% | $14,036,830.66 | 450,187 |
|
-
Enliven Therapeutics, Inc.
|
0.71% | $13,558,980.26 | 328,862 |
|
-
Relay Therapeutics, Inc.
|
0.70% | $13,334,544.00 | 1,028,900 |
|
-
APPLIED MATERIALS INC /DE
|
0.67% | $12,768,320.30 | 6,300 |
|
-
Tyra Biosciences, Inc.
|
0.65% | $12,308,450.00 | 354,200 |
|
-
Zenas BioPharma, Inc.
|
0.62% | $11,803,051.68 | 610,924 |
|
-
Olema Pharmaceuticals, Inc.
|
0.59% | $11,199,452.00 | 777,200 |
|
-
Celldex Therapeutics, Inc.
|
0.59% | $11,184,197.76 | 340,152 |
|
-
Travere Therapeutics, Inc.
|
0.56% | $10,681,632.00 | 253,600 |
|
-
CG Oncology, Inc.
|
0.55% | $10,524,898.00 | 157,700 |
|
-
Stoke Therapeutics, Inc.
|
0.55% | $10,395,144.00 | 317,700 |
|
-
Annexon, Inc.
|
0.51% | $9,753,005.00 | 1,661,500 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.50% | $9,554,348.88 | 117,433 |
|
-
CytomX Therapeutics, Inc.
|
0.49% | $9,406,595.22 | 2,229,051 |
|
-
Disc Medicine, Inc.
|
0.49% | $9,386,135.90 | 142,322 |
|
-
MBX Biosciences, Inc.
|
0.48% | $9,205,012.00 | 304,600 |
|
-
Mineralys Therapeutics, Inc.
|
0.46% | $8,823,815.00 | 331,100 |
Advertisement (320x50)